(Q43595918)

English

Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms (English)

1 reference

Europe PubMed Central

25 November 2017

Alexander R Haug

7

1 reference

Europe PubMed Central

25 November 2017

Maximilian Reiser

9

object named as

Maximilian F Reiser

1 reference

Europe PubMed Central

25 November 2017

10

object named as

Wieland H Sommer

1 reference

Europe PubMed Central

25 November 2017

author name string

Marco Armbruster

1

1 reference

Europe PubMed Central

25 November 2017

Christoph J Zech

2

1 reference

Europe PubMed Central

25 November 2017

Steven Sourbron

3

1 reference

Europe PubMed Central

25 November 2017

Felix Ceelen

4

1 reference

Europe PubMed Central

25 November 2017

Christoph J Auernhammer

5

1 reference

Europe PubMed Central

25 November 2017

Carsten Rist

6

1 reference

Europe PubMed Central

25 November 2017

Amit Singnurkar

8

1 reference

Europe PubMed Central

25 November 2017

publication date

18 December 2013

1 reference

Europe PubMed Central

25 November 2017

Journal of Magnetic Resonance Imaging

1 reference

Europe PubMed Central

25 November 2017

40

1 reference

Europe PubMed Central

25 November 2017

2

1 reference

Europe PubMed Central

25 November 2017

457-466

1 reference

Europe PubMed Central

25 November 2017

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Imaging appearances of metastases from neuroendocrine tumours of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Primovist, Eovist: what to expect?

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Role of PET/CT in the functional imaging of endocrine pancreatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Hepatic metastases: in vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment tracer kinetics model.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Perfusion magnetic resonance imaging of the liver

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Radiolabelling DOTA-peptides with 68Ga

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Dynamic contrast-enhanced MR imaging of the liver: current status and future directions

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Hypervascular liver lesions

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Angiogenesis in neuroendocrine tumors: therapeutic applications

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Mechanism of hepatic uptake of gadoxetate disodium.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Partial-volume effect in PET tumor imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24363

21 January 2018

Identifiers

10.1002/JMRI.24363

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43595918&oldid=2101777983"